(Q37644021)

English

Advances in the biology and therapy of patients with chronic myeloid leukaemia

scientific article published on September 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

title

Advances in the biology and therapy of patients with chronic myeloid leukaemia (English)

1 reference

stated in

Europe PubMed Central

21 August 2017

1 reference

3

Hagop Kantarjian

1 reference

stated in

Europe PubMed Central

21 August 2017

1

Elias Jabbour

1 reference

stated in

Europe PubMed Central

21 August 2017

Carmen Fava

2

1 reference

stated in

Europe PubMed Central

21 August 2017

1 September 2009

1 reference

stated in

Europe PubMed Central

21 August 2017

Best Practice and Research: Clinical Haematology

1 reference

stated in

Europe PubMed Central

21 August 2017

22

1 reference

stated in

Europe PubMed Central

21 August 2017

3

1 reference

stated in

Europe PubMed Central

21 August 2017

395-407

1 reference

stated in

Europe PubMed Central

21 August 2017

Synergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1158/1078-0432.CCR-07-0835

Identifiers

DOI

10.1016/J.BEHA.2009.09.002

1 reference

stated in

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

PubMed ID

19959090

retrieved

21 August 2017

(Q37644021)

Advances in the biology and therapy of patients with chronic myeloid leukaemia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)